| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 03/20/2008 | CA2663279A1 Use of 2-6-(3-amino-piperidin-1-yl)-3-methyl-2,-4-dioxo-3,4-dihydro-2h-pyridimin-1-ylmethyl-4-fluoro-benzonitrile for treating diabetes, cancer,autoimmune disorders and hiv infection |
| 03/20/2008 | CA2663234A1 Novel phenylacetic acid derivative |
| 03/20/2008 | CA2662879A1 2-phenoxynicotinic acid derivatives and use thereof |
| 03/20/2008 | CA2661892A1 Gel type enteral nutrient |
| 03/19/2008 | EP1900815A2 In vivo production of small interfering RNAs that mediate gene silencing |
| 03/19/2008 | EP1900739A1 Diazolodiazine derivatives as kinase inhibitors |
| 03/19/2008 | EP1900738A2 Substituted pyrroline kinase inhibitors |
| 03/19/2008 | EP1900736A1 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione and pharmaceutical compositions comprising the same |
| 03/19/2008 | EP1900728A1 Pharmaceutical composition comprising pyrazolone derivative |
| 03/19/2008 | EP1900721A1 Substituted cyclic compound, its preparation process and its medical use |
| 03/19/2008 | EP1900367A2 Hypoglycemic agent |
| 03/19/2008 | EP1900366A2 Hypoglycemic agent |
| 03/19/2008 | EP1900364A2 Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors |
| 03/19/2008 | EP1900360A1 Homer a new target of treating psychiatric disorders |
| 03/19/2008 | EP1899353A1 Thienopyrimidines for pharmaceutical compositions |
| 03/19/2008 | EP1899309A1 Heterocyclic compounds as agonists for the thyroid receptor |
| 03/19/2008 | EP1899304A1 5-amino-1h-pyrazole-3-carboxylic acid derivatives as agonists for the g-protein coupled receptor (gpcr) rup38 for the treatment of metabolic-related disorders thereof |
| 03/19/2008 | EP1899302A1 Phenoxy acetic acids as ppar delta activators |
| 03/19/2008 | EP1898926A2 Thyromimetics for the treatment of fatty liver diseases |
| 03/19/2008 | EP1898922A2 Improved drug or pharmaceutical compounds and a preparation thereof |
| 03/19/2008 | EP1898906A2 Methods of treatment utilizing certain melatonin derivatives |
| 03/19/2008 | EP1898897A2 Methods and related compositions for treating or preventing obesity, insulin resistance disorders, and mitochondrial-associated disorders |
| 03/19/2008 | EP1898724A2 Infant nutrition with hydrolised proteins |
| 03/19/2008 | EP1898709A1 Fungicide composition comprising a phosphorous acid derivative, a mandelamide type compound and a further fungicide compound |
| 03/19/2008 | EP1713804B1 Cycloalkyl substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, method for the production thereof and their use as medicaments |
| 03/19/2008 | EP1682122B1 Combinations of valsartan, amiloride or triamterine, and a diuretic |
| 03/19/2008 | EP1562933B1 Substituted amine derivatives and methods of use in the treatment of angiogenesis related disorders |
| 03/19/2008 | EP1499316B1 (1-4-piperidinyl)benzimidazole derivatives useful as histamine h3 antagonists |
| 03/19/2008 | EP1442024B1 AMINOBENZAMIDE DERIVATIVES AS GLYCOGEN SYNTHASE KINASE 3$g(b) INHIBITORS |
| 03/19/2008 | EP1362031B1 Pharmaceutically active piperidine derivatives |
| 03/19/2008 | EP1149091B1 4-(heterocyclylsulfonamido)-5-methoxy-6-(2-methoxyphenoxy)-2-phenyl- or pyridylpyrimidines as endothelin receptor antagonists |
| 03/19/2008 | EP1042293B1 Substituted pyridine and pyridazine compounds and their pharmaceutical use |
| 03/19/2008 | CN101146809A Process for preparing quinoline compounds and products obtained therefrom |
| 03/19/2008 | CN101146805A Production method for thiazolidinedione compound and its production intermediate |
| 03/19/2008 | CN101146801A New salt and polymorphs of a dpp-iv inhibitor |
| 03/19/2008 | CN101146766A Acyl hydrazides as kinase inhibitors, in particular for SGK |
| 03/19/2008 | CN101144094A Fermentation manufacturing technique for alpha-glycosidase inhibitor |
| 03/19/2008 | CN101144082A Recombination human ciliary neurotrophy factor, mutant and application thereof |
| 03/19/2008 | CN101143869A Aldose reductase inhibitor structure and synthesis method thereof |
| 03/19/2008 | CN101143868A Aldose reductase inhibitor structure and use |
| 03/19/2008 | CN101143210A Compound fatty milk oral preparation |
| 03/19/2008 | CN101143207A Application of natural type, breaking type or No. 5 domain delation variant type beta 2 glycoprotein I in preparing medicine for inhibiting blood vessel newborn |
| 03/19/2008 | CN101143192A Therapeutic gastrodia extracts |
| 03/19/2008 | CN101143189A Traditional Chinese medicinal composition for treating hyperlipemia and its preparation method and quality control method |
| 03/19/2008 | CN101143180A Medicine for treating diabetes |
| 03/19/2008 | CN101143172A Traditional Chinese medicine for treating obesity in children |
| 03/19/2008 | CN101143168A Technology for preparing haw total phenolic acid part |
| 03/19/2008 | CN101143158A Oral preparation for treating diabetes |
| 03/19/2008 | CN101143131A Method for preparing human insulin inhaled dry powder using with supercritical fluid technology |
| 03/18/2008 | US7345180 Compound inhibiting dipeptidyl peptidase IV |
| 03/18/2008 | US7345151 Antagonists specific for denatured collagen and methods of using same |
| 03/18/2008 | US7345085 Indoles having anti-diabetic activity |
| 03/18/2008 | US7345070 Side effects reduction; Diabetes mellitus, Syndrome X, Type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, atherosclerosis; 3-{4-[2-(2-phenyl-5-methyl-oxazol-4-yl)-ethoxy]-phenyl}-2-methyl-2-phenoxy-propionic acid |
| 03/18/2008 | US7345067 peroxisome proliferator activators such as (2-methyl-4-{methyl-[4-methyl-2-(4-trifluoromethyl-phenyl)-thiazol-5-ylmethyl]-amino}-phenoxy)-acetic acid, used as lipid modulators and insulin sensitizers |
| 03/18/2008 | US7345065 Using adrenergic receptors; side effect reduction |
| 03/18/2008 | US7345050 Imidazo(1,2a)pyridine or pyrazolo(2,3a)pyridine derivatives; Alzheimer's and Parkinson's Disease; nervous system, brain, and psychological disorders |
| 03/18/2008 | US7344843 Identifying modulators of transmembrane protein (PROLIXIN) for use in prevention and treatment of hyperlipidemia, athersclerosis, insulin resistance, diabetes and hypertension |
| 03/18/2008 | US7344713 Decreased fat absorption with an anti-lipase antibody |
| 03/18/2008 | CA2355776C Phospholipid complexes of proanthocyanidin a2 as antiatherosclerotic agents |
| 03/18/2008 | CA2335015C Carnitine and inositol phosphate-containing composition useful as dietary supplement or drug |
| 03/18/2008 | CA2323839C Treatment of neuropathy |
| 03/18/2008 | CA2121689C 1.alpha.,24(s)-dihydroxy vitamin d2, its formation and use |
| 03/13/2008 | WO2008030891A2 Inhibition of fatty acid synthesis by parp inhibitors and methods of treatment thereof |
| 03/13/2008 | WO2008030579A2 Irak modulators for treating an inflammatory condition, cell proliferative disorder, immune disorder |
| 03/13/2008 | WO2008030520A1 Heterocyclic gpr40 modulators |
| 03/13/2008 | WO2008030382A1 Pharmaceutical combinations for lipid management and in the treatment of atherosclerosis and hepatic steatosis |
| 03/13/2008 | WO2008029869A1 Agent for prevention or treatment of blood glucose level elevation |
| 03/13/2008 | WO2008029846A1 Lipase inhibitor |
| 03/13/2008 | WO2008029790A1 Novel nucleic acid |
| 03/13/2008 | WO2008029619A1 Ena antisense oligonucleotide having sequence-specific action |
| 03/13/2008 | WO2008029565A1 Compound having inhibitory activity on histone deacetylase, and pharmaceutical comprising the compound as active ingredient |
| 03/13/2008 | WO2008029511A1 Insulin sensitivity improving agent |
| 03/13/2008 | WO2008029505A1 Agent for accelerating the increase in and/or preventing the decrease in blood adiponectin level, and visceral fat accumulation inhibitor |
| 03/13/2008 | WO2008029266A1 Stearoyl coa desaturase inhibitors |
| 03/13/2008 | WO2008028958A1 Cyclic sulfones useful as mitochondrial sodium-calcium exchangers |
| 03/13/2008 | WO2008028928A1 Novel combination of agents for the treatment of hiv-associated adipose redistribution syndrome (hars) |
| 03/13/2008 | WO2008028914A1 Combination treatment for diabetes mellitus |
| 03/13/2008 | WO2008028662A1 N-[1-(3-amino-4-phenyl-butyryl)-4-hydroxy-pyrrolidin-2-ylmethyl}-propionamide and related compounds as dpp-iv inhibitors for the treatment of type 2 diabetes mellitus |
| 03/13/2008 | WO2008028300A1 Oral polymeric membrane feruloyl esterase producing bacteria formulation |
| 03/13/2008 | WO2008028250A1 Therapeutic agents, targets and diagnostics |
| 03/13/2008 | WO2008009813A3 Use of an extract of gleditsia in cosmetics and in dermatology |
| 03/13/2008 | WO2008005624A3 Method of treatment of hereditary hemochromatosis |
| 03/13/2008 | WO2007150063A3 Compositions for lowering blood serum cholesterol and use in foods, beverages, and health supplements |
| 03/13/2008 | WO2007148185A3 Substituted 3 -amino- pyrrolidino-4 -lactams as dpp inhibitors |
| 03/13/2008 | WO2007136116A3 C-phenyl glycitol compound for the treatment of diabetes |
| 03/13/2008 | WO2007134460A8 Pancreatic b-cells expressing abca1 and uses thereof |
| 03/13/2008 | WO2007126365A3 Further medical uses of antisecretory protein |
| 03/13/2008 | WO2007113540A3 Regulating fat and carbohydrate oxidation in muscle tissue comprising controlling carnitine content in muscle |
| 03/13/2008 | WO2007112753A3 Pharmaceutical composition comprising anti-mirna antisense oligonucleotides |
| 03/13/2008 | WO2007092065A3 Compounds and compositions as lxr modulators |
| 03/13/2008 | WO2007053819A3 Pyrrolidinyl beta-amino amide-based inhibitors of dipeptidyl peptidase iv and methods |
| 03/13/2008 | WO2007041053A3 Formulation comprising metformin and vildagli ptin |
| 03/13/2008 | WO2006106372A8 New crystalline atorvastatin hemicalcium salt polymorph form |
| 03/13/2008 | US20080064759 Process for preparing fenofibrate compositions |
| 03/13/2008 | US20080064753 Interleukin-1 and tumor necrosis factor-alpha modulators; syntheses of such modulators and methods of using such modulators |
| 03/13/2008 | US20080064751 Utilizing lipoxin analogs; polyisoprenyl phosphate signaling inhibition |
| 03/13/2008 | US20080064734 Mixture with other active materials; controlling glucose metabolism; diabetes |
| 03/13/2008 | US20080064731 Remedy for chronic disease |
| 03/13/2008 | US20080064728 Heterocyclic Compounds Useful as Dpp-Iv Inhibitors |
| 03/13/2008 | US20080064726 Dipeptidyl peptidase-IV (DPP-IV) inhibitor; diabetes mellitus, insulin-resistant diseases, obesity, hypoglycemia ; 2-[4-({2-[(2S,4S)-2-cyano-4-fluoropyrrolidin-1-yl]-2-oxoethyl}amino)-4-methylpiperdin-1-yl]-2-oxoethyl acetate monofumarate |